118 related articles for article (PubMed ID: 24801085)
1. Plasma PCSK9 levels are associated with the severity of coronary stenosis in patients with atherosclerosis.
Li S; Guo YL; Xu RX; Zhang Y; Zhu CG; Sun J; Qing P; Wu NQ; Li JJ
Int J Cardiol; 2014 Jul; 174(3):863-4. PubMed ID: 24801085
[No Abstract] [Full Text] [Related]
2. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
[TBL] [Abstract][Full Text] [Related]
3. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
[TBL] [Abstract][Full Text] [Related]
4. Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.
Zhu YM; Anderson TJ; Sikdar K; Fung M; McQueen MJ; Lonn EM; Verma S
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2254-9. PubMed ID: 26293463
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of pitavastatin versus pravastatin on serum proprotein convertase subtilisin/kexin type 9 levels in statin-naive patients with coronary artery disease.
Nozue T; Hattori H; Ishihara M; Iwasaki T; Hirano T; Kawashiri MA; Yamagishi M; Michishita I
Am J Cardiol; 2013 May; 111(10):1415-9. PubMed ID: 23433768
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease.
Li S; Guo YL; Xu RX; Zhang Y; Zhu CG; Sun J; Qing P; Wu NQ; Jiang LX; Li JJ
Atherosclerosis; 2014 Jun; 234(2):441-5. PubMed ID: 24769476
[TBL] [Abstract][Full Text] [Related]
8. Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.
Li S; Xu RX; Zhang Y; Guo YL; Zhu CG; Liu G; Dong Q; Li JJ
J Endocrinol Invest; 2015 Dec; 38(12):1291-9. PubMed ID: 26003826
[TBL] [Abstract][Full Text] [Related]
9. Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study.
Li JJ; Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q
Medicine (Baltimore); 2015 Dec; 94(52):e2426. PubMed ID: 26717403
[TBL] [Abstract][Full Text] [Related]
10. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
Cameron J; Bogsrud MP; Tveten K; Strøm TB; Holven K; Berge KE; Leren TP
Transl Res; 2012 Aug; 160(2):125-30. PubMed ID: 22683370
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the plasma PCSK9 levels and platelet indices in patients with stable coronary artery disease.
Li S; Zhu CG; Guo YL; Xu RX; Zhang Y; Sun J; Li JJ
J Atheroscler Thromb; 2015; 22(1):76-84. PubMed ID: 25185779
[TBL] [Abstract][Full Text] [Related]
14. PCSK9 and lipid lowering drugs.
Guo YL; Zhang W; Li JJ
Clin Chim Acta; 2014 Nov; 437():66-71. PubMed ID: 25036764
[TBL] [Abstract][Full Text] [Related]
15. Plasma PCSK9 is a late biomarker of severity in patients with severe trauma injury.
Le Bras M; Roquilly A; Deckert V; Langhi C; Feuillet F; Sébille V; Mahé PJ; Bach K; Masson D; Lagrost L; Costet P; Asehnoune K; Cariou B
J Clin Endocrinol Metab; 2013 Apr; 98(4):E732-6. PubMed ID: 23450051
[TBL] [Abstract][Full Text] [Related]
16. Association of serum proprotein convertase subtilisin/kexin type 9 with carotid intima media thickness in hypertensive subjects.
Lee CJ; Lee YH; Park SW; Kim KJ; Park S; Youn JC; Lee SH; Kang SM; Jang Y
Metabolism; 2013 Jun; 62(6):845-50. PubMed ID: 23380568
[TBL] [Abstract][Full Text] [Related]
17. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Leander K; Mälarstig A; Van't Hooft FM; Hyde C; Hellénius ML; Troutt JS; Konrad RJ; Öhrvik J; Hamsten A; de Faire U
Circulation; 2016 Mar; 133(13):1230-9. PubMed ID: 26896437
[TBL] [Abstract][Full Text] [Related]
18. Marine n-3 polyunsaturated fatty acids lower plasma proprotein convertase subtilisin kexin type 9 levels in pre- and postmenopausal women: A randomised study.
Graversen CB; Lundbye-Christensen S; Thomsen B; Christensen JH; Schmidt EB
Vascul Pharmacol; 2016 Jan; 76():37-41. PubMed ID: 26143741
[TBL] [Abstract][Full Text] [Related]
19. Relationship of proprotein convertase subtilisin-kexin type 9 levels with resistin in lean and obese subjects.
Kwakernaak AJ; Lambert G; Dullaart RP
Clin Biochem; 2012 Nov; 45(16-17):1522-4. PubMed ID: 22809551
[TBL] [Abstract][Full Text] [Related]
20. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
